Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

IIT Clinical Trial on Tolerance, Safety, and Preliminary Efficacy of KSX01-TCRT Injection in Solid Tumor Subjects

NCT05811975 is registered in ClinicalTrials.gov with TCRx Therapeutics Co.Ltd as lead sponsor.

NCT NCT05811975
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05811975 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
IIT Clinical Trial on Tolerance, Safety, and Preliminary Efficacy of KSX01-TCRT Injection in Solid Tumor Subjects
Lead sponsor
TCRx Therapeutics Co.Ltd
Phase
Phase 1
Overall status
Recruiting
Start date
March 7, 2023
Completion date
December 31, 2028
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

refractory solid tumors, relapsed solid tumors, tcr-t cells